메뉴 건너뛰기




Volumn 16, Issue 1, 2008, Pages 21-29

Long-term effects of non-surgical therapy for obesity on cardiovascular risk management: A weighted empirical review

Author keywords

Cardiovascular risk profile; Non surgical therapy; RCTs; Weight loss

Indexed keywords

ACARBOSE; METFORMIN; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

EID: 37549067782     PISSN: 09431853     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10389-007-0161-x     Document Type: Review
Times cited : (5)

References (48)
  • 2
    • 0034969354 scopus 로고    scopus 로고
    • Emergence of obesity and cardiovascular risk for coronary artery disease: The Bogalusa Heart Study
    • 3
    • Berenson GS, Srinivasan SR (2001) Emergence of obesity and cardiovascular risk for coronary artery disease: the Bogalusa Heart Study. Prev Cardiol 4(3):116-121
    • (2001) Prev Cardiol , vol.4 , pp. 116-121
    • Berenson, G.S.1    Srinivasan, S.R.2
  • 3
    • 0038455703 scopus 로고    scopus 로고
    • Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance
    • for The STOP-NIDDM Trial Research Group
    • Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, for The STOP-NIDDM Trial Research Group (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. JAMA 290:486-494
    • (2003) JAMA , vol.290 , pp. 486-494
    • Chiasson, J.L.1    Josse, R.G.2    Gomis, R.3    Hanefeld, M.4    Karasik, A.5    Laakso, M.6
  • 6
    • 33749864985 scopus 로고    scopus 로고
    • Management issues in the metabolic syndrome
    • Deedwania PC, Gupta R (2006) Management issues in the metabolic syndrome. J Assoc Physicians India 54:797-810
    • (2006) J Assoc Physicians India , vol.54 , pp. 797-810
    • Deedwania, P.C.1    Gupta, R.2
  • 7
    • 27844463517 scopus 로고    scopus 로고
    • Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
    • 20
    • Despres JP, Golay A, Sjostrom L (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353(20):2121-2134
    • (2005) N Engl J Med , vol.353 , pp. 2121-2134
    • Despres, J.P.1    Golay, A.2    Sjostrom, L.3
  • 8
    • 0037034257 scopus 로고    scopus 로고
    • Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
    • Diabetes Prevention Program Research Group
    • Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403
    • (2002) N Engl J Med , vol.346 , pp. 393-403
  • 9
    • 0032951713 scopus 로고    scopus 로고
    • Metabolic and weight-loss effects of a long-term dietary intervention in obese patients
    • Ditschuneit HH, Fletchner-Mors M, Johnson TD, Adler G (1999) Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr 69:198-204
    • (1999) Am J Clin Nutr , vol.69 , pp. 198-204
    • Ditschuneit, H.H.1    Fletchner-Mors, M.2    Johnson, T.D.3    Adler, G.4
  • 10
    • 30544443423 scopus 로고    scopus 로고
    • Systematic review of long-term weight loss studies in obese adults: Clinical significance and applicability to clinical practice
    • 10
    • Douketis JD, Macie C, Thabane L, Williamson DF (2005) Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes (Lond) 29(10):1153-1167
    • (2005) Int J Obes (Lond) , vol.29 , pp. 1153-1167
    • Douketis, J.D.1    MacIe, C.2    Thabane, L.3    Williamson, D.F.4
  • 11
  • 12
    • 33747114039 scopus 로고    scopus 로고
    • Preventing cardiovascular disease and diabetes: A call to action from the American Diabetes Association and the American Heart Association
    • 25
    • Eckel RH, Kahn R, Robertson RM, Rizza RA (2006) Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 113(25):2943-2946
    • (2006) Circulation , vol.113 , pp. 2943-2946
    • Eckel, R.H.1    Kahn, R.2    Robertson, R.M.3    Rizza, R.A.4
  • 13
    • 4544288392 scopus 로고    scopus 로고
    • Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial
    • 12
    • Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292(12):1440-1446
    • (2004) JAMA , vol.292 , pp. 1440-1446
    • Esposito, K.1    Marfella, R.2    Ciotola, M.3    Di Palo, C.4    Giugliano, F.5    Giugliano, G.6    D'Armiento, M.7    D'Andrea, F.8    Giugliano, D.9
  • 14
    • 0034710221 scopus 로고    scopus 로고
    • Effects of walking training on weight maintenance after a very-low-energy diet in premenopausal obese women: A randomized controlled trial
    • 14
    • Fogelholm M, Kukkonen-Harjula K, Nenonen A, Pasanen M (2000) Effects of walking training on weight maintenance after a very-low-energy diet in premenopausal obese women: a randomized controlled trial. Arch Intern Med 160(14):2177-2184
    • (2000) Arch Intern Med , vol.160 , pp. 2177-2184
    • Fogelholm, M.1    Kukkonen-Harjula, K.2    Nenonen, A.3    Pasanen, M.4
  • 15
    • 0026753155 scopus 로고
    • Beneficial health effects of modest weight loss
    • 6
    • Goldstein DJ (1992) Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 16(6):397-415
    • (1992) Int J Obes Relat Metab Disord , vol.16 , pp. 397-415
    • Goldstein, D.J.1
  • 16
    • 0033829586 scopus 로고    scopus 로고
    • Orlistat in the long-term treatment of obesity in primary care settings
    • 2
    • Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR (2000) Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med 9(2):160-167
    • (2000) Arch Fam Med , vol.9 , pp. 160-167
    • Hauptman, J.1    Lucas, C.2    Boldrin, M.N.3    Collins, H.4    Segal, K.R.5
  • 18
    • 33846815271 scopus 로고    scopus 로고
    • Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus
    • 2 Suppl 1
    • Hollander P (2007) Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus. Am J Med 120(2 Suppl 1):S18-28; discussion S29-32
    • (2007) Am J Med , vol.120
    • Hollander, P.1
  • 19
    • 0025233478 scopus 로고
    • The hypertension prevention trial: Three-year effects of dietary changes on blood pressure
    • Hypertension Prevention Trial Research Group. 1
    • Hypertension Prevention Trial Research Group (1990) The hypertension prevention trial: three-year effects of dietary changes on blood pressure. Arch Intern Med 150(1):153-162
    • (1990) Arch Intern Med , vol.150 , pp. 153-162
  • 20
    • 1542472257 scopus 로고    scopus 로고
    • What is 'metabolic domino effect'?-new concept in lifestyle-related diseases
    • 10
    • Itoh H (2003) What is 'metabolic domino effect'?-new concept in lifestyle-related diseases. Nippon Rinsho 61(10):1837-1843
    • (2003) Nippon Rinsho , vol.61 , pp. 1837-1843
    • Itoh, H.1
  • 21
    • 0034516930 scopus 로고    scopus 로고
    • Effect of sibutramine on weight maintenance after weight loss: A randomised trial. STORM study group. Sibutramine trial of obesity reduction and maintenance
    • 9248
    • James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH, Van Gaal LF (2000) Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM study group. Sibutramine trial of obesity reduction and maintenance. Lancet 356(9248):2119-2125
    • (2000) Lancet , vol.356 , pp. 2119-2125
    • James, W.P.1    Astrup, A.2    Finer, N.3    Hilsted, J.4    Kopelman, P.5    Rossner, S.6    Saris, W.H.7    Van Gaal, L.F.8
  • 25
    • 0031669704 scopus 로고    scopus 로고
    • Obesity-what are the current treatment options?
    • Suppl 2
    • Lean ME (1998) Obesity-what are the current treatment options? Exp Clin Endocrinol Diabetes 106(Suppl 2):22-26
    • (1998) Exp Clin Endocrinol Diabetes , vol.106 , pp. 22-26
    • Lean, M.E.1
  • 26
    • 33846921614 scopus 로고    scopus 로고
    • Weight management for type 2 diabetes mellitus: Global cardiovascular risk reduction
    • 4A
    • Lee M, Aronne LJ (2007) Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. Am J Cardiol 99(4A):68B-79B
    • (2007) Am J Cardiol , vol.99
    • Lee, M.1    Aronne, L.J.2
  • 28
    • 0842346052 scopus 로고    scopus 로고
    • Screening and interventions for obesity in adults: Summary of the evidence for the US Preventive services task force
    • 11
    • McTigue KM, Harris R, Hemphill B, Lux L, Sutton S, Bunton AJ, Lohr KN (2003) Screening and interventions for obesity in adults: summary of the evidence for the US Preventive services task force. Ann Intern Med 139(11):933-949
    • (2003) Ann Intern Med , vol.139 , pp. 933-949
    • McTigue, K.M.1    Harris, R.2    Hemphill, B.3    Lux, L.4    Sutton, S.5    Bunton, A.J.6    Lohr, K.N.7
  • 29
    • 2142688132 scopus 로고    scopus 로고
    • Lifestyle intervention according to general recommendations improves glucose tolerance
    • 12
    • Mensink M, Blaak EE, Corpeleijn E, Saris WH, de Bruin TW, Feskens EJ (2003) Lifestyle intervention according to general recommendations improves glucose tolerance. Obes Res 11(12):1588-1596
    • (2003) Obes Res , vol.11 , pp. 1588-1596
    • Mensink, M.1    Blaak, E.E.2    Corpeleijn, E.3    Saris, W.H.4    De Bruin, T.W.5    Feskens, E.J.6
  • 30
    • 16544374656 scopus 로고    scopus 로고
    • Diagnosis and treatment of obesity in adults: An applied evidence-based review
    • 5
    • Orzano AJ, Scott JG (2004) Diagnosis and treatment of obesity in adults: an applied evidence-based review. J Am Board Fam Pract 17(5):359-369
    • (2004) J Am Board Fam Pract , vol.17 , pp. 359-369
    • Orzano, A.J.1    Scott, J.G.2
  • 33
    • 32644441249 scopus 로고    scopus 로고
    • Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: A randomized controlled trial
    • 7
    • Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295(7):761-775
    • (2006) JAMA , vol.295 , pp. 761-775
    • Pi-Sunyer, F.X.1    Aronne, L.J.2    Heshmati, H.M.3    Devin, J.4    Rosenstock, J.5
  • 34
    • 0017853234 scopus 로고
    • Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients
    • 1
    • Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B (1978) Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 298(1):1-6
    • (1978) N Engl J Med , vol.298 , pp. 1-6
    • Reisin, E.1    Abel, R.2    Modan, M.3    Silverberg, D.S.4    Eliahou, H.E.5    Modan, B.6
  • 35
    • 33845968044 scopus 로고    scopus 로고
    • Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients
    • Richelsen B, Tonstad S, Rossner S, Toubro S, Niskanen L, Madsbad S, Mustajoki P, Rissanen A (2007) Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients. Diabetes Care 30:27-32
    • (2007) Diabetes Care , vol.30 , pp. 27-32
    • Richelsen, B.1    Tonstad, S.2    Rossner, S.3    Toubro, S.4    Niskanen, L.5    Madsbad, S.6    Mustajoki, P.7    Rissanen, A.8
  • 36
    • 0033629936 scopus 로고    scopus 로고
    • Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group
    • 1
    • Rossner S, Sjostrom L, Noack R, Meinders AE, Noseda G (2000) Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res 8(1):49-61
    • (2000) Obes Res , vol.8 , pp. 49-61
    • Rossner, S.1    Sjostrom, L.2    Noack, R.3    Meinders, A.E.4    Noseda, G.5
  • 37
    • 2542619763 scopus 로고    scopus 로고
    • Obesity and cardiovascular risk: The new public health problem of worldwide proportion
    • 2
    • Scaglione R, Argano C, Di Chiara T, Licata G (2004) Obesity and cardiovascular risk: the new public health problem of worldwide proportion. Expert Rev Cardiovasc Ther 2(2):203-212
    • (2004) Expert Rev Cardiovasc Ther , vol.2 , pp. 203-212
    • Scaglione, R.1    Argano, C.2    Di Chiara, T.3    Licata, G.4
  • 38
    • 33645342228 scopus 로고    scopus 로고
    • Scientific evidence of interventions using the Mediterranean diet: A systematic review
    • 2 Pt 2
    • Serra-Majem L, Roman B, Estruch R (2006) Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev 64(2 Pt 2):S27-S47
    • (2006) Nutr Rev , vol.64
    • Serra-Majem, L.1    Roman, B.2    Estruch, R.3
  • 39
    • 42749104338 scopus 로고    scopus 로고
    • (No. CD003817. DOI 10.1002/14651858.CD003817.pub3. ) Hamilton, US. The cochrane database of systematic reviews
    • Shaw K, Gennat H, O'Rourke P, Del Mar C (2007a) Exercise for overweight or obesity. (No. CD003817. DOI 10.1002/14651858.CD003817.pub3. ) Hamilton, US. The cochrane database of systematic reviews
    • (2007) Exercise for Overweight or Obesity
    • Shaw, K.1    Gennat, H.2    O'Rourke, P.3    Del Mar, C.4
  • 42
    • 0034820062 scopus 로고    scopus 로고
    • Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance
    • 4
    • Swinburn B, Metcalf PA, Ley SJ (2001) Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care 24(4):619-624
    • (2001) Diabetes Care , vol.24 , pp. 619-624
    • Swinburn, B.1    Metcalf, P.A.2    Ley, S.J.3
  • 43
    • 1042303480 scopus 로고    scopus 로고
    • XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients
    • 1
    • Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27(1):155-161
    • (2004) Diabetes Care , vol.27 , pp. 155-161
    • Torgerson, J.S.1    Hauptman, J.2    Boldrin, M.N.3    Sjostrom, L.4
  • 44
    • 17144382751 scopus 로고    scopus 로고
    • Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
    • 9468
    • Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365(9468):1389-1397
    • (2005) Lancet , vol.365 , pp. 1389-1397
    • Van Gaal, L.F.1    Rissanen, A.M.2    Scheen, A.J.3    Ziegler, O.4    Rossner, S.5
  • 45
    • 0034941433 scopus 로고    scopus 로고
    • Detection, evaluation, and treatment of high blood cholesterol in adults
    • Various. 5
    • Various (2001) Detection, evaluation, and treatment of high blood cholesterol in adults. Rev Panam Salud Publica 9(5):338-344
    • (2001) Rev Panam Salud Publica , vol.9 , pp. 338-344
  • 47
    • 0031909881 scopus 로고    scopus 로고
    • Lifestyle intervention in overweight individuals with a family history of diabetes
    • 3
    • Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W (1998) Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care 21(3):350-359
    • (1998) Diabetes Care , vol.21 , pp. 350-359
    • Wing, R.R.1    Venditti, E.2    Jakicic, J.M.3    Polley, B.A.4    Lang, W.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.